Review article
Are the antidiabetic SGLT2 inhibitors a cardiovascular treatment?
¿Son los inhibidores del receptor SGLT2 fármacos antidiabéticos o cardiovasculares?
Ariana P. Vargas Delgado, Juan Antonio Requena Ibañez
, Carlos G. Santos-Gallego, Juan Jose Badimon
Corresponding author
Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, United States
Read
3491
Timeswas read the article
847
Total PDF
2644
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 53 | 49 | 102 |
| 2025 11 | 128 | 182 | 310 |
| 2025 10 | 45 | 49 | 94 |
| 2025 9 | 61 | 48 | 109 |
| 2025 8 | 62 | 44 | 106 |
| 2025 7 | 82 | 31 | 113 |
| 2025 6 | 57 | 17 | 74 |
| 2025 5 | 57 | 22 | 79 |
| 2025 4 | 43 | 16 | 59 |
| 2025 3 | 52 | 9 | 61 |
| 2025 2 | 55 | 9 | 64 |
| 2025 1 | 69 | 9 | 78 |
| 2024 12 | 41 | 6 | 47 |
| 2024 11 | 40 | 4 | 44 |
| 2024 10 | 35 | 10 | 45 |
| 2024 9 | 48 | 13 | 61 |
| 2024 8 | 46 | 4 | 50 |
| 2024 7 | 36 | 5 | 41 |
| 2024 6 | 25 | 8 | 33 |
| 2024 5 | 17 | 9 | 26 |
| 2024 4 | 35 | 17 | 52 |
| 2024 3 | 43 | 8 | 51 |
| 2024 2 | 43 | 6 | 49 |
| 2024 1 | 102 | 12 | 114 |
| 2023 12 | 41 | 11 | 52 |
| 2023 11 | 58 | 8 | 66 |
| 2023 10 | 71 | 13 | 84 |
| 2023 9 | 54 | 9 | 63 |
| 2023 8 | 41 | 3 | 44 |
| 2023 7 | 67 | 10 | 77 |
| 2023 6 | 76 | 9 | 85 |
| 2023 5 | 85 | 17 | 102 |
| 2023 4 | 96 | 3 | 99 |
| 2023 3 | 89 | 13 | 102 |
| 2023 2 | 65 | 7 | 72 |
| 2023 1 | 73 | 16 | 89 |
| 2022 12 | 74 | 23 | 97 |
| 2022 11 | 126 | 10 | 136 |
| 2022 10 | 60 | 9 | 69 |
| 2022 9 | 52 | 15 | 67 |
| 2022 8 | 43 | 13 | 56 |
| 2022 7 | 58 | 25 | 83 |
| 2022 6 | 35 | 14 | 49 |
| 2022 5 | 44 | 13 | 57 |
| 2022 4 | 21 | 8 | 29 |
| 2022 3 | 26 | 7 | 33 |
| 2022 2 | 14 | 4 | 18 |
Show all